• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Swine flu vaccine imports OK'd

Ronan Kelly

Retired 2020
Thursday, Jan. 21, 2010


Swine flu vaccine imports OK'd
Kyodo News
The Health, Labor and Welfare Ministry approved Wednesday the domestic use of swine flu vaccines made by British and Swiss companies, paving the way for their distribution around early February with inoculations beginning in midmonth.

Japan has concluded import contracts with the two companies, with vaccines for 7.4 million people to be purchased from Britain's GlaxoSmithKline PLC and 2.5 million from Novartis AG of Switzerland.

The new batch of vaccines is for inoculation of healthy adults who have not been vaccinated for the flu so far.

Because Japan has secured from foreign and domestic sources more than enough H1N1 vaccines for the entire population, the government is studying the feasibility of canceling part of the purchase contracts.
http://search.japantimes.co.jp/cgi-bin/nn20100121a9.html
 
Back
Top Bottom